These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8462802)

  • 1. Immunogenicity of inactivated hepatitis A vaccine in children.
    Lee SD; Lo KJ; Chan CY; Yu MY; Wang YJ; Safary A
    Gastroenterology; 1993 Apr; 104(4):1129-32. PubMed ID: 8462802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactogenicity and immunogenicity of three different lots of a hepatitis A vaccine.
    Theilmann L; Kallinowski B; Gmelin K; Hofmann F; Scheiermann N; Wohland B; Stickl H; Maiwald H; Moriabadi FK; Bock HL
    Vaccine; 1992; 10 Suppl 1():S132-4. PubMed ID: 1335644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of hepatitis A vaccine in healthy children.
    Horng YC; Chang MH; Lee CY; Safary A; Andre FE; Chen DS
    Pediatr Infect Dis J; 1993 May; 12(5):359-62. PubMed ID: 8392163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children.
    Castillo de Febres O; Chacon de Petrola M; Casanova de Escalona L; Naveda O; Naveda M; Estopinan M; Bordones G; Zambrano B; Garcia A; Dumas R
    Vaccine; 1999 Nov; 18(7-8):656-64. PubMed ID: 10547425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease.
    Lee SD; Chan CY; Yu MI; Wang YJ; Chang FY; Lo KJ; Safary A
    J Med Virol; 1997 Jun; 52(2):215-8. PubMed ID: 9179771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of an inactivated hepatitis A vaccine in healthy children: two years' follow-up.
    Lee WT; Chang MH; Lee CY; Chen DS; Safary A; Andre FE
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(5):331-5. PubMed ID: 8607357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters.
    Lee SD; Chan CY; Yu MI; Wang YJ; Lo KJ; Safary A
    Am J Gastroenterol; 1996 Jul; 91(7):1360-2. PubMed ID: 8677995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous passive and active immunization against hepatitis A.
    Leentvaar-Kuijpers A; Coutinho RA; Brulein V; Safary A
    Vaccine; 1992; 10 Suppl 1():S138-41. PubMed ID: 1335646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals.
    Davidson M; Krugman S; Sandman LA
    Vaccine; 1992; 10 Suppl 1():S119-20. PubMed ID: 1335639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and safety of an inactivated hepatitis A vaccine amongst Singaporeans.
    Guan R; Ng HS; Fock KM; Ho KY; Yap I; Kang JY; Chow WC; Chew CN; Ng C; Teo CJ
    Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):268-71. PubMed ID: 8629058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence.
    Van Damme P; Thoelen S; Cramm M; De Groote K; Safary A; Meheus A
    J Med Virol; 1994 Dec; 44(4):446-51. PubMed ID: 7897379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine.
    Dagan R; Greenberg D; Goldenbertg-Gehtman P; Vidor E; Briantais P; Pinsk V; Athias O; Dumas R
    Vaccine; 1999 Apr; 17(15-16):1919-25. PubMed ID: 10217590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of vaccine-induced antibody to hepatitis A virus.
    Wiedermann G; Ambrosch F; André FE; D'Hondt E; Delem A; Safary A
    Vaccine; 1992; 10 Suppl 1():S129-31. PubMed ID: 1335643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity, safety and tolerability of varying doses and regimens of inactivated hepatitis A virus vaccine in Navajo children.
    Newcomer W; Rivin B; Reid R; Moulton LH; Wolff M; Croll J; Johnson C; Brown L; Nalin D; Santosham M
    Pediatr Infect Dis J; 1994 Jul; 13(7):640-2. PubMed ID: 7970954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up.
    Dagan R; Greenberg D; Weber F
    Vaccine; 2005 Oct; 23(44):5144-8. PubMed ID: 16043271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals.
    Sandman L; Davidson M; Krugman S
    J Infect Dis; 1995 Mar; 171 Suppl 1():S50-2. PubMed ID: 7876649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children.
    Balcarek KB; Bagley MR; Pass RF; Schiff ER; Krause DS
    J Infect Dis; 1995 Mar; 171 Suppl 1():S70-2. PubMed ID: 7876652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children.
    Lee CY; Huang LM; Lee PI; Chiu HH; Dumas R; Milcamps B; Lin W
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):29-36. PubMed ID: 11023061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivated hepatitis A vaccine in childhood: implications for disease control.
    Nalin D; Brown L; Kuter B; Patterson C; McGuire B; Werzberger A; Santosham M; Block S; Reisinger K; Watson B
    Vaccine; 1993; 11 Suppl 1():S15-7. PubMed ID: 8383388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of a pediatric formulation of inactivated hepatitis A vaccine in Argentinean children.
    López EL; Del Carmen Xifró M; Torrado LE; De Rosa MF; Gómez R; Dumas R; Wood SC; Contrini MM
    Pediatr Infect Dis J; 2001 Jan; 20(1):48-52. PubMed ID: 11176566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.